Threat of mutant Covid strain prompted approval for Covaxin, reveal minutes of SEC meetings
Threat of mutant Covid strain prompted approval for Covaxin, reveal minutes of SEC meetings
Minutes of meetings held between December 30 and January 2 show that the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) changed its stance concerning Bharat Biotech s coronavirus vaccine Covaxin.
advertisement
[REPRESENTATIVE IMAGE] (Photo Credits: PTI)
The looming danger of the new mutant strain found in the UK may have turned the odds against Bharat Biotech with respect to its efforts to receive emergency use authorisation for its Covid-19 vaccine Covaxin. India now has 71 cases of the mutant strain with numbers climbing rapidly.